600080.SS
Ginwa Enterprise (Group) Inc. [600080.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600080.SS Stock Summary
Top 10 Correlated ETFs
600080.SS
Top 10 Correlated Stocks
600080.SS
In the News
600080.SS Financial details
Company Rating
-
Market Cap
2.66B
Income
5.02M
Revenue
559.03M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
600
Optionable
No
Shortable
Yes
Earnings
23 Apr 2021
P/E
570.46
Forward P/E
-
PEG
-44.74
P/S
5.09
P/B
1.7
P/C
-
P/FCF
11.28
Quick Ratio
2.46
Current Ratio
2.55
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-283.98%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.02%
Revenue last 5Y
-4.91%
Revenue Q/Q
0.22%
EPS Q/Q
-120.45%
-
-
-
-
SMA20
14.29%
SMA50
-
SMA100
14.29%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
76%
Oper. Margin
1%
Profit Margin
1%
Payout
47%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.53-8.1
52W High
+4.38%
52W Low
+108.75%
RSI
70
Rel Volume
3.02
Avg Volume
5.34M
Volume
16.13M
Perf Week
6.51%
Perf Month
15.81%
Perf Quarter
11.33%
Perf Half Y
16.13%
-
-
-
-
Beta
0.233
-
-
Volatility
0.28%, 0.37%
Prev Close
-2%
Price
8.35
Change
-4.46%
Company Profile
- Volume Average 5.34M
- Market Capitalization 2.66B
- Employee 600
- CEO Ms. Yajuan Ju
- Headquarters Xi'an,CN
- IPO Date 1997-06-12
-
Website
https://www.ginwa.com.cn 
Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells proprietary Chinese, biological, and chemical medicines in China. It offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. The company provides its products in the form of capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. is based in Xi'an, China.
